Abbott Laboratories

Ultime notizie

Titoli nella lingua originale della fonte.

• Abbott Laboratories stock outperforms competitors despite losses on the day (si apre in una nuova scheda)

  MarketWatch · 1 ott 2026

• Abbott settled a government infant formula lawsuit for nearly $385 million. (si apre in una nuova scheda)

  Claim Depot · 1 ott 2026

• Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026? (si apre in una nuova scheda)

  The Motley Fool · 1 ott 2026

• 
  Abbott Stock And Other Healthcare Dividend Names Built For Supply Chain Shocks (si apre in una nuova scheda)

  Simply Wall St. · 1 ott 2026

• In 1935, An Illinois Secretary Bought 3 Shares Of Her Company’s Stock For $180. She Never Sold A Single Share And Always Reinvested Dividends. By The Time She Died In 2010 Her 3 Abbott Shares Had Turned Into $7.2 Million. (si apre in una nuova scheda)

  24/7 Wall St. · 1 ott 2026

• Abbott Laboratories’ Quarterly Earnings Preview: What You Need to Know (si apre in una nuova scheda)

  inkl · 1 ott 2026

• Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), Tectonic Therapeutic (TECX) (si apre in una nuova scheda)

  The Globe and Mail · 1 ott 2026

• DOJ Announces $385 Million Settlement to Resolve False Claims Allegations over Abbott Laboratories Baby Formula (si apre in una nuova scheda)

  MedLearn Publishing · 1 ott 2026

• Abbott (ABT) Sees a More Significant Dip Than Broader Market: Some Facts to Know (si apre in una nuova scheda)

  Zacks · 30 set 2026

• Abbott (ABT) Stock May Be 25% Stretched After Biosensor Market Forecast (si apre in una nuova scheda)

  Simply Wall Street · 30 set 2026

• Abbott Laboratories stock underperforms Wednesday when compared to competitors (si apre in una nuova scheda)

  MarketWatch · 30 set 2026

• AG Fitch Announces False Claims Settlement with Abbott Laboratories (si apre in una nuova scheda)

  MageeNews.com · 30 set 2026

• Mississippi to receive more than $771K in $384 million Abbott Laboratories settlement (si apre in una nuova scheda)

  Darkhorse Press · 30 set 2026

• Abbott Laboratories (ABT) Launches SimpleScreen CRC As Fair Value Stays In Focus (si apre in una nuova scheda)

  Simply Wall St. · 30 set 2026

• Mississippi to Receive $771K in $384M False Claims Settlement with Abbott Laboratories (si apre in una nuova scheda)

  tippahnews.com · 30 set 2026

• Mississippi receives $771K in Abbott formula settlement (si apre in una nuova scheda)

  WJTV · 30 set 2026

• Abbott Laboratories (NYSE:ABT): Are Investors Getting Over Their Scepticism Over The Company's Bold US$21bn Bet On Exact Sciences? (si apre in una nuova scheda)

  Stocks Down Under · 29 set 2026

• Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal (si apre in una nuova scheda)

  Zacks · 29 set 2026

• 3 Historically Stable Dividend Raisers in Medical Devices Offering Solid Yields With Fortress-Like Growth (si apre in una nuova scheda)

  24/7 Wall St. · 29 set 2026

• How Big Could BSX Stock's Next Fall Be? (si apre in una nuova scheda)

  Trefis · 28 set 2026

• Abbott lawsuit alleges spinal cord stimulators can fail, worsen nerve damage (si apre in una nuova scheda)

  Top Class Actions · 28 set 2026

• Gilead vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward? (si apre in una nuova scheda)

  Yahoo Finance · 27 set 2026

• At $103.99 a share, an Abbott Laboratories (ABT) director delivered or withheld shares for exercise costs or taxes. (si apre in una nuova scheda)

  Stock Titan · 25 set 2026

• NVST vs. ABT: Which Stock Is the Better Value Option? (si apre in una nuova scheda)

  Zacks · 25 set 2026

• How Lingo Partnership Will Impact Abbott Stock (ABT) (si apre in una nuova scheda)

  Simply Wall Street · 24 set 2026

• Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note (si apre in una nuova scheda)

  Yahoo Finance · 24 set 2026

• FDA Advisors Said It Should Approve the Grail Multicancer Blood Test. The Stock Rises Sharply. (si apre in una nuova scheda)

  Barrons.com · 24 set 2026

• Abbott Laboratories (ABT) is Facing Segment Competition and Sluggish Nutrition Recovery (si apre in una nuova scheda)

  Yahoo Finance · 24 set 2026

• Is Abbott’s Digital Health Push and Formula Settlement Altering The Investment Case For Abbott (ABT)? (si apre in una nuova scheda)

  Simply Wall St. · 23 set 2026

• Here's Why You Should Hold Stryker Stock in Your Portfolio for Now (si apre in una nuova scheda)

  Zacks · 23 set 2026